These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 10558530

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug 28; 65(167):52016-8. PubMed ID: 11067735
    [Abstract] [Full Text] [Related]

  • 5. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human); confirmation in part and technical amendment. Food and Drug Administration, HHS. Direct final rule; confirmation in part and technical amendment.
    Fed Regist; 2000 Mar 14; 65(50):13678-9. PubMed ID: 11010647
    [Abstract] [Full Text] [Related]

  • 6. Revision to requirements for licensed Anti-Human Globulin and Blood Grouping Reagents. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Dec 12; 65(239):77497-9. PubMed ID: 11503726
    [Abstract] [Full Text] [Related]

  • 7. Revisions to the requirements applicable to blood, blood components and source plasma. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Aug 16; 72(158):45883-88. PubMed ID: 17847577
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Revocation of status of specific products; Group A streptococcus. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2005 Dec 02; 70(231):72197-9. PubMed ID: 16323338
    [Abstract] [Full Text] [Related]

  • 11. Amendment to examination and investigation sample requirements--FDA. Direct final rule.
    Fed Regist; 1998 Sep 25; 63(186):51297-9. PubMed ID: 10185810
    [Abstract] [Full Text] [Related]

  • 12. Blood vessels recovered with organs and intended for use in organ transplantation. Direct final rule.
    Food and Drug Administration, Health Resources and Services Administration, (HHS).
    Fed Regist; 2006 May 12; 71(92):27606-10. PubMed ID: 16696153
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Investigational new drug applications; clinical holds--FDA. Direct final rule.
    Fed Regist; 1998 Dec 14; 63(239):68676-8. PubMed ID: 10187558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quality mammography standards. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule.
    Fed Regist; 1999 Jun 17; 64(116):32404-7. PubMed ID: 10558582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.